Steven Helwig - Aug 24, 2021 Form 3 Insider Report for Radius Health, Inc. (RDUS)

Role: Principal Financial Officer
Signature: /s/ Averi Price, as attorney-in-fact
Stock symbol: RDUS
Transactions as of: Aug 24, 2021
Transactions value $: $0
Form type: 3
Date filed: 8/26/2021, 04:35 PM
Next filing: Jan 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RDUS	Common Stock						15.7K	Aug 24, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RDUS	Stock Option (Right to Buy)							Aug 24, 2021	Common Stock	10.8K	$63.34	Direct	F2
holding	RDUS	Stock Option (Right to Buy)							Aug 24, 2021	Common Stock	3.5K	$19.18	Direct	F3
holding	RDUS	Stock Option (Right to Buy)							Aug 24, 2021	Common Stock	3.5K	$20.25	Direct	F4
holding	RDUS	Stock Option (Right to Buy)							Aug 24, 2021	Common Stock	12.3K	$21.66	Direct	F5
holding	RDUS	Stock Option (Right to Buy)							Aug 24, 2021	Common Stock	20K	$18.60	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The amount reflected includes 375 restricted stock units awarded under the 2011 Equity Incentive Plan and 4,542 restricted stock units awarded under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The shares underlying the restricted stock units vest as follows: (a) 375 of such shares shall vest on February 13, 2022; (b) 1,000 of such shares shall vest as to 50% on February 22, 2022 and 50% on February 22, 2023; (c) 1,667 of such shares shall vest as to 50% on March 2, 2022 and 50% on March 2, 2023; and (d) 1,875 of such shares shall vest as to 33.33% on November 9, 2021 and as to 33.33% annually thereafter over the following two years on November 9 of each year.
F2	The shares subject to this stock option are fully vested and exercisable.
F3	25% of the shares subject to this stock option vested on February 22, 2020; and the remaining shares have vested or shall vest in substantially equal monthly installments over 36 months thereafter.
F4	25% of the shares are subject to this stock option vested on March 2, 2021; and the remaining shares have vested or shall vest in substantially equal monthly installments over 36 months thereafter.
F5	25% of the shares subject to this stock option shall vest on January 20, 2022; and the remaining shares shall vest in substantially equal monthly installments over 36 months thereafter.
F6	25% of the shares subject to this stock option shall vest on February 22, 2022; and the remaining shares shall vest in substantially equal monthly installments over 36 months thereafter.